Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Initiation of a phase I/Ib trial of TG-1050

May 15, 2015

Phase I trial initiated for Emergent and GSK Ebola virus vaccine prime-boost regimen

May 15, 2015

Bavarian Nordic reports results of pivotal trials of liquid-frozen and freeze-dried Imvamune

May 14, 2015

Inovio starts phase I trial of Ebola virus DNA vaccine

May 14, 2015

Antiviral fusion inhibitor presatovir, a promising candidate to treat RSV infection

May 14, 2015

Preliminary phase I results of Ebola prime-boost vaccine regimen of MVA-BN Filo and AdVac

May 13, 2015

NAPs show promising sequence-independent antiviral activity

May 13, 2015

FDA designates Cidara's CD-101 IV as QIDP

May 13, 2015

Janssen patents new anti-HBV compounds

May 12, 2015

FDA accepts Gemmus' IND for GP-1681 to alleviate influenza symptoms

May 12, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...